• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6

CATEGORIES

  • 7
  • 5
  • 1
  • 1
  • 1
  • 1

PRICE

1
7
7
12

PUBLISHED

0
1
3
12

PRODUCT TYPE

11
1

Search "Global Hemophilia Treatment Market 2010-2014" returned 12 results.

PRODUCT TITLE
Global Hemophilia Market Report: 2012 Edition Global Hemophilia Market Report: 2012 Edition - Product Thumbnail Image

Global Hemophilia Market Report: 2012 Edition

With an ever changing technological environment and an unstable economic scenario, many scientific studies are being conducted which are leading to the discovery of new coagulation factors, proteins...

June 2012
FROM
Global Hemophilia Market Report: 2013 Edition Global Hemophilia Market Report: 2013 Edition - Product Thumbnail Image

Global Hemophilia Market Report: 2013 Edition

Hemophilia is a disorder in which the blood does not clot properly, leading to extended bleeding The bleeding can be external or internal, especially in the knees, ankles, and elbows There are two types...

October 2013
FROM

Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline

“Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline”, provides in-depth analysis of unmet needs, drivers...

September 2011
FROM

Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth

“Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth” provides in-depth analysis of drivers and barriers that...

September 2011
FROM
Global Blood Plasma Market Report: 2013 Edition Global Blood Plasma Market Report: 2013 Edition - Product Thumbnail Image

Global Blood Plasma Market Report: 2013 Edition

Plasma is a composite mixture of more than 700 proteins and other substances which are vital for the smooth functioning of the human body Plasma is the liquid component of blood, constituting around...

March 2013
FROM

The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities

“The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities” provides in-depth analysis of unmet needs,...

March 2010
FROM
Human Albumin and Factor Vlll (FVIII) Markets: An Analysis Human Albumin and Factor Vlll (FVIII) Markets: An Analysis - Product Thumbnail Image

Human Albumin and Factor Vlll (FVIII) Markets: An Analysis

The global blood plasma-derived products market has shown consistent growth over the period 2002-2009 and the rapid increase in cases of Hemophilia, low treatment cost to patients and rising ageing...

April 2011
FROM
Global Blood Plasma Market Report: 2014 Edition Global Blood Plasma Market Report: 2014 Edition - Product Thumbnail Image

Global Blood Plasma Market Report: 2014 Edition

Plasma is a composite mixture of more than 700 proteins and other substances which are vital for the smooth functioning of the human body Plasma is the liquid component of blood, constituting around...

July 2014
FROM

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

September 2009
FROM
Global Human Growth Hormone Market Report: 2012 Edition Global Human Growth Hormone Market Report: 2012 Edition - Product Thumbnail Image

Global Human Growth Hormone Market Report: 2012 Edition

Pituitary- the master gland of human body is responsible for controlling crucial hormonal secretion which in turn regulates other key aspects of human body such as temperature, growth, thyroid functioning,...

October 2012
FROM

Biogen Idec Inc. (BIIB) - Financial and Strategic SWOT Analysis Review

Biogen Idec Inc. (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

March 2015
FROM
Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 - Product Thumbnail Image

Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020

Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon Patent expiration is the major driving factor of...

July 2014
FROM
Loading Indicator

Our Clients

Intel Corporation Autodesk, Inc. Hewlett-Packard Company Ahlstrom Corporation SAP SE 3M Company Samsung Group Ltd.